About the Company
Amneal Pharmaceuticals, Inc. is an American publicly traded generics and specialty pharmaceutical company. The company is headquartered in Bridgewater, New Jersey.
Exchange
NYSE
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $AMRX News
Strength Seen in Amneal (AMRX): Can Its 12.0% Jump Turn into More Strength?
Amneal (AMRX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in ...
Amneal Pharmaceuticals, Inc. (AMRX)
BRIDGEWATER, N.J., March 01, 2024--Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) ("Amneal" or the "Company") today announced its results for the fourth quarter and full year ended December 31 ...
Amneal Pharmaceuticals Shares Rise 9% After FDA Approves Naloxone Spray
By Chris Wack Amneal Pharmaceuticals shares were up 9% after the Food and Drug Administration approved an abbreviated new drug application ...
Amneal's OTC Naloxone Nasal Spray Receives FDA Approval For Opioid Overdose Emergency Treatment
(RTTNews) - Amneal Pharmaceuticals, Inc. (AMRX) announced on Wednesday that it has received FDA approval for its Over the Counter Naloxone Hydrochloride or HCI Nasal Spray, USP, 4mg. This nasal spray ...
Bausch (BHC) Starts Litigation Against Amneal for Xifaxan
Bausch Health BHC, along with its gastroenterology business, Salix Pharmaceuticals, Inc., announced that it has filed a ...
Amneal Pharmaceuticals Inc Ordinary Shares - Class A
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Analysts Conflicted on These Healthcare Names: Amneal Pharmaceuticals (AMRX) and Community Health (CYH)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Amneal Pharmaceuticals (AMRX – Research Report) and ...
Amneal Pharmaceuticals gets grant for gastroretentive dosage form for extended release of pyridostigmine
Discover Amneal Pharmaceuticals' innovative patent for extended-release pyridostigmine dosage forms, featuring unique copolymer membranes for improved drug release and patient compliance. Explore the ...
New Suit - Patent
Counsel have not yet appeared for the defendant. The case is 3:24-cv-04607, Salix Pharmaceuticals, Inc. v. Amneal Pharmaceuticals Of New York, LLC.
Amneal Launches PEMRYDI RTU®, the First Ready-to-Use Version of Important Oncology Injectable Medicine
Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) today announced the launch of PEMRYDI RTU ®, the first and only ready-to-use presentation of pemetrexed for injection. This ...
Loading the latest forecasts...